Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,912,916
-$1,620,859 QoQ
Shares Held
411,666
+0.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#430
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2025CallValue
$239,040
CallShares
9,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. PFE ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
This page
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
|
26,885 | $9,735,596 |
All Filings in PFE
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,912,916 | 411,666 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,533,775 | 410,747 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $239,040 | 9,600 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $9,478,682 | 380,670 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,519,145 | 216,607 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,815,299 | 198,651 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,403,078 | 173,760 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,329,430 | 163,190 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $289,400 | 10,000 | Call | Sole | 2024-10-24 | |
| 2024-09-30 | $4,879,023 | 168,591 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,548,098 | 198,288 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,560,906 | 164,357 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,484,712 | 121,039 | Shares | Sole | 2024-01-24 | |
| 2023-12-31 | $719,750 | 25,000 | Call | Sole | 2024-01-24 | |
| 2023-09-30 | $3,901,554 | 117,623 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,432,917 | 93,591 | Shares | Sole | 2023-07-26 | |
| 2023-06-30 | $1,100,400 | 30,000 | Call | Sole | 2023-07-26 | |
| 2023-03-31 | $1,632,000 | 40,000 | Call | Sole | 2023-05-02 | |
| 2023-03-31 | $3,569,265 | 87,482 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,465,053 | 87,140 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $3,900,503 | 89,134 | Shares | Sole | 2022-10-21 | |
| 2022-09-30 | $1,312,800 | 30,000 | Call | Sole | 2022-10-21 | |
| 2022-06-30 | $4,395,940 | 83,844 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $4,130,003 | 79,776 | Shares | Sole | 2022-05-02 | |
| 2022-03-31 | $1,035,400 | 20,000 | Call | Sole | 2022-05-02 | |
| 2021-12-31 | $5,145,144 | 87,132 | Shares | Sole | 2022-02-03 | |
| 2021-12-31 | $1,476,250 | 25,000 | Call | Sole | 2022-02-03 | |
| 2021-09-30 | $3,171,944 | 73,749 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,529,187 | 64,586 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,192,510 | 32,915 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $725,782 | 19,717 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $379,734 | 10,347 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $257,087 | 7,862 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $261,511 | 8,012 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||